Difference between revisions of "Mucoepidermoid carcinoma"
Jump to navigation
Jump to search
(+cat.) |
(split-out) |
||
Line 1: | Line 1: | ||
# | '''Mucoepidermoid carcinoma''', abbreviated ''MEC'', the is the most common malignant neoplasm of the [[salivary gland]]. | ||
==General== | |||
*Most common malignant neoplasm of salivary gland in all age groups.<ref>URL: [http://path.upmc.edu/cases/case715/dx.html http://path.upmc.edu/cases/case715/dx.html]. Accessed on: 2 February 2012.</ref> | |||
*Female:male ~= 3:2. | |||
*Site: parotid > submandibular. | |||
==Gross== | |||
*Cystic or solid, usu. a mix of both. | |||
==Microscopic== | |||
Features: | |||
*Architecture:<ref>URL: [http://moon.ouhsc.edu/kfung/jty1/opaq/PathQuiz/D2A001-PQ01-M.htm http://moon.ouhsc.edu/kfung/jty1/opaq/PathQuiz/D2A001-PQ01-M.htm]. Accessed on: 19 October 2010.</ref> | |||
**Cystic (low grade). | |||
**Solid (high grade). | |||
*Mucous cells with abundant fluffy cytoplasm and large mucin vacuoles - '''key feature'''. | |||
**Nucleus distorted by mucin vacuole. | |||
**Mucous cell may be scarce - more difficult to diagnose. | |||
*Epidermoid cells: | |||
**Non-keratinized, polygonal squamoid cell with clear or oncocytic cytoplasm. | |||
***Clear cells contain glycogen ([[PAS]] +ve, [[PAS-D]] -ve). | |||
Notes: | |||
*The classic description - composed of 3 cell types: epidermoid, intermediate, and mucin producing.<ref>{{Cite journal | last1 = Lennerz | first1 = JK. | last2 = Perry | first2 = A. | last3 = Mills | first3 = JC. | last4 = Huettner | first4 = PC. | last5 = Pfeifer | first5 = JD. | title = Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion. | journal = Am J Surg Pathol | volume = 33 | issue = 6 | pages = 835-43 | month = Jun | year = 2009 | doi = 10.1097/PAS.0b013e318190cf5b | PMID = 19092631 }}</ref> | |||
**"Intermediate cells" are described in textbooks. Weinreb thinks they are a pretty much a myth.<ref name=IW_10jan2011>IW. 10 January 2011.</ref> | |||
*Mucin vacuoles may be rare; in a superficial glance -- it may mimic [[squamous cell carcinoma]]. | |||
*The thought of high-grade MEC should prompt consideration of squamous cell carcinoma. | |||
===Images=== | |||
<gallery> | |||
Image:Mucoepidermoid_carcinoma_%282%29_HE_stain.jpg | Mucoepidermoid carcinoma 2. (WC) | |||
Image:Mucoepidermoid_carcinoma_%283%29_HE_stain.jpg | Mucoepidermoid carcinoma 3. (WC) | |||
Image:Mucoepidermoid_carcinoma_-_2_-_intermed_mag.jpg | Mucoepidermoid carcinoma - 2 - intermed. mag. (WC/Nephron) | |||
Image:Mucoepidermoid_carcinoma_-_2_-_high_mag.jpg | Mucoepidermoid carcinoma - 2 - high mag. (WC/Nephron) | |||
Image:Mucoepidermoid_carcinoma_-_2a_-_very_high_mag.jpg | Mucoepidermoid carcinoma - 2 - very high mag. (WC/Nephron) | |||
</gallery> | |||
www: | |||
*[http://moon.ouhsc.edu/kfung/jty1/opaq/PathQuiz/D2A001-PQ01-M.htm Mucoepidermoid carcinoma (ouhsc.edu)]. | |||
===Subtypes=== | |||
*Conventional. | |||
*Oncocytic. | |||
**Definition: composed of 50% oncocytes. | |||
**Good outcome.<ref name=pmid18971778>{{cite journal |author=Weinreb I, Seethala RR, Perez-Ordoñez B, Chetty R, Hoschar AP, Hunt JL |title=Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases |journal=Am. J. Surg. Pathol. |volume=33 |issue=3 |pages=409–16 |year=2009 |month=March |pmid=18971778 |doi=10.1097/PAS.0b013e318184b36d |url=}}</ref> | |||
*Clear cell. | |||
*Unicystic (cystadenocarcinoma). | |||
**Based on the gross. (???) | |||
*Sclerosing MEC +/- eosinophilia. | |||
**Rare. | |||
===Grading=== | |||
General: | |||
*Two competing system exist: | |||
**AFIP.<ref name=pmid9529011>{{cite journal |author=Goode RK, Auclair PL, Ellis GL |title=Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria |journal=Cancer |volume=82 |issue=7 |pages=1217–24 |year=1998 |month=April |pmid=9529011 |doi= |url=}}</ref> | |||
**Brandwein.<ref name=pmid11420454>{{cite journal |author=Brandwein MS, Ivanov K, Wallace DI, ''et al.'' |title=Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading |journal=Am. J. Surg. Pathol. |volume=25 |issue=7 |pages=835–45 |year=2001 |month=July |pmid=11420454 |doi= |url=}}</ref> | |||
Notes: | |||
*Both systems have their pros and cons. | |||
*Weinreb uses the AFIP system with a slight modification. | |||
====AFIP==== | |||
#Low cystic content (<20%) - 2 points. | |||
#[[Perineural invasion]] - 2 points. | |||
#[[Necrosis]] - 3 points. | |||
#Mitoses > 4 per 10 HPFs (HPF not defined in paper - see [[HPFitis]]) - 3 points. | |||
#Anaplasia - 4 points. | |||
Scoring: | |||
*Low grade = 0-4 points. | |||
*Intermediate grade = 5-6 points. | |||
*High grade = 7+ points. | |||
=====Weinreb modification===== | |||
Weinreb looks for the following: | |||
*Tumour invades in small nests/islands - 2 points. | |||
**If applicable, the two points are added to the AFIP score. | |||
**The tumour is graded using the AFIP (scoring) cut points -- see above. | |||
Notes: | |||
*It seems pointless to memorize this but it is occasionally asked on exams. | |||
**How to remember: think of the Nottingham grading system (architecture, mitoses, nuclear grade) + necrosis + LVI. | |||
==Stains== | |||
Mucous cells: | |||
*Alcian blue +ve. | |||
*Mucicarcmine +ve. | |||
==Molecular== | |||
*t(11;19)(q21;p13) -- MECT1-MAML2 fusion.<ref name=pmid12539049>{{cite journal |author=Tonon G, Modi S, Wu L, ''et al.'' |title=t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway |journal=Nat. Genet. |volume=33 |issue=2 |pages=208–13 |year=2003 |month=February |pmid=12539049 |doi=10.1038/ng1083 |url=}}</ref><ref name=pmid20588178>{{cite journal |author=Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN |title=A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas |journal=Am. J. Surg. Pathol. |volume=34 |issue=8 |pages=1106–21 |year=2010 |month=August |pmid=20588178 |doi=10.1097/PAS.0b013e3181de3021 |url=}}</ref> | |||
**Present in ~65% of MECs. | |||
**Presence assoc. with low-grade MEC (vs. high-grade MEC) & favourable prognosis. | |||
**Not seen in tumours that are in the DDx of MEC. | |||
==See also== | |||
*[[Salivary glands]]. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||
[[Category:Salivary glands]] |
Revision as of 01:55, 27 October 2013
Mucoepidermoid carcinoma, abbreviated MEC, the is the most common malignant neoplasm of the salivary gland.
General
- Most common malignant neoplasm of salivary gland in all age groups.[1]
- Female:male ~= 3:2.
- Site: parotid > submandibular.
Gross
- Cystic or solid, usu. a mix of both.
Microscopic
Features:
- Architecture:[2]
- Cystic (low grade).
- Solid (high grade).
- Mucous cells with abundant fluffy cytoplasm and large mucin vacuoles - key feature.
- Nucleus distorted by mucin vacuole.
- Mucous cell may be scarce - more difficult to diagnose.
- Epidermoid cells:
Notes:
- The classic description - composed of 3 cell types: epidermoid, intermediate, and mucin producing.[3]
- "Intermediate cells" are described in textbooks. Weinreb thinks they are a pretty much a myth.[4]
- Mucin vacuoles may be rare; in a superficial glance -- it may mimic squamous cell carcinoma.
- The thought of high-grade MEC should prompt consideration of squamous cell carcinoma.
Images
www:
Subtypes
- Conventional.
- Oncocytic.
- Definition: composed of 50% oncocytes.
- Good outcome.[5]
- Clear cell.
- Unicystic (cystadenocarcinoma).
- Based on the gross. (???)
- Sclerosing MEC +/- eosinophilia.
- Rare.
Grading
General:
Notes:
- Both systems have their pros and cons.
- Weinreb uses the AFIP system with a slight modification.
AFIP
- Low cystic content (<20%) - 2 points.
- Perineural invasion - 2 points.
- Necrosis - 3 points.
- Mitoses > 4 per 10 HPFs (HPF not defined in paper - see HPFitis) - 3 points.
- Anaplasia - 4 points.
Scoring:
- Low grade = 0-4 points.
- Intermediate grade = 5-6 points.
- High grade = 7+ points.
Weinreb modification
Weinreb looks for the following:
- Tumour invades in small nests/islands - 2 points.
- If applicable, the two points are added to the AFIP score.
- The tumour is graded using the AFIP (scoring) cut points -- see above.
Notes:
- It seems pointless to memorize this but it is occasionally asked on exams.
- How to remember: think of the Nottingham grading system (architecture, mitoses, nuclear grade) + necrosis + LVI.
Stains
Mucous cells:
- Alcian blue +ve.
- Mucicarcmine +ve.
Molecular
- t(11;19)(q21;p13) -- MECT1-MAML2 fusion.[8][9]
- Present in ~65% of MECs.
- Presence assoc. with low-grade MEC (vs. high-grade MEC) & favourable prognosis.
- Not seen in tumours that are in the DDx of MEC.
See also
References
- ↑ URL: http://path.upmc.edu/cases/case715/dx.html. Accessed on: 2 February 2012.
- ↑ URL: http://moon.ouhsc.edu/kfung/jty1/opaq/PathQuiz/D2A001-PQ01-M.htm. Accessed on: 19 October 2010.
- ↑ Lennerz, JK.; Perry, A.; Mills, JC.; Huettner, PC.; Pfeifer, JD. (Jun 2009). "Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.". Am J Surg Pathol 33 (6): 835-43. doi:10.1097/PAS.0b013e318190cf5b. PMID 19092631.
- ↑ IW. 10 January 2011.
- ↑ Weinreb I, Seethala RR, Perez-Ordoñez B, Chetty R, Hoschar AP, Hunt JL (March 2009). "Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases". Am. J. Surg. Pathol. 33 (3): 409–16. doi:10.1097/PAS.0b013e318184b36d. PMID 18971778.
- ↑ Goode RK, Auclair PL, Ellis GL (April 1998). "Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria". Cancer 82 (7): 1217–24. PMID 9529011.
- ↑ Brandwein MS, Ivanov K, Wallace DI, et al. (July 2001). "Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading". Am. J. Surg. Pathol. 25 (7): 835–45. PMID 11420454.
- ↑ Tonon G, Modi S, Wu L, et al. (February 2003). "t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway". Nat. Genet. 33 (2): 208–13. doi:10.1038/ng1083. PMID 12539049.
- ↑ Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN (August 2010). "A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas". Am. J. Surg. Pathol. 34 (8): 1106–21. doi:10.1097/PAS.0b013e3181de3021. PMID 20588178.